Javascript must be enabled to continue!
Disclosing the diagnosis of Alzheimer’s disease
View through CrossRef
Diagnostic disclosure of Alzheimer’s disease is generally accepted to be good practice; however, there are important factors for clinicians to consider when preparing to impart such a serious diagnosis. In particular, this chapter explores the issues around timing of the disclosure and determining the correct amount of information to give. It highlights the need for good knowledge of the individual—knowledge of the person’s current mental capacity, the person’s own views, as well as those of the family—in order to provide really good care. It also addresses issues of uncertainty such as making a very early diagnosis and giving an accurate prognosis. The chapter suggests that it is the person (rather than the professional) who should control the situation, and that professionals must be attuned to what the person and family require from them. It also highlights the need for sound post-diagnostic support and follow-up.
Title: Disclosing the diagnosis of Alzheimer’s disease
Description:
Diagnostic disclosure of Alzheimer’s disease is generally accepted to be good practice; however, there are important factors for clinicians to consider when preparing to impart such a serious diagnosis.
In particular, this chapter explores the issues around timing of the disclosure and determining the correct amount of information to give.
It highlights the need for good knowledge of the individual—knowledge of the person’s current mental capacity, the person’s own views, as well as those of the family—in order to provide really good care.
It also addresses issues of uncertainty such as making a very early diagnosis and giving an accurate prognosis.
The chapter suggests that it is the person (rather than the professional) who should control the situation, and that professionals must be attuned to what the person and family require from them.
It also highlights the need for sound post-diagnostic support and follow-up.
Related Results
Alzheimer’s Disease
Alzheimer’s Disease
Advances in the current management and treatment of Alzheimer’s disease have grown directly from our increased understanding of the neurobiology underlying this disease. Currently ...
Alzheimer's Disease (Oxford Neurology Library)
Alzheimer's Disease (Oxford Neurology Library)
Providing clinicians with the latest developments in research, this new edition of Alzheimer's Disease is a succinct and practical introduction to the diagnosis, evaluation, and ma...
Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)
Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)
The video in this chapter explores dementia, and focuses on definitions of dementia, Alzheimer’s disease and Frontotemporal Dementia. Dementia is defined as a cognitive decline in ...
Diagnosing Alzheimer’s disease in clinical practice
Diagnosing Alzheimer’s disease in clinical practice
The diagnostic evaluation in a patient with cognitive impairment suspected of having Alzheimer’s disease (AD) should include investigations aimed at 1) confirming and characterizin...
Diagnosing Alzheimer’s disease in clinical practice
Diagnosing Alzheimer’s disease in clinical practice
• In the current clinical criteria, the diagnosis of Alzheimer’s disease (AD) is a clinical diagnosis based on characteristic symptoms and signs, and the exclusion of other causes....
Rheumatoid arthritis—management
Rheumatoid arthritis—management
Influential guidelines on rheumatoid arthritis (RA) management agree on most key recommendations. Early diagnosis of persistent synovitis, and identification of poor prognostic mar...
A History of Multiple Sclerosis
A History of Multiple Sclerosis
While we now recognize that MS is a common neurological disease, as late as the early twentieth century it was considered a relatively rare condition in Europe and the United State...
Frontotemporal dementia
Frontotemporal dementia
Frontotemporal dementia (FTD) is the second most common form of dementia in persons younger than 65 years after Alzheimer’s disease. The FTD spectrum is characterized by clinical, ...

